Musclepharm To Present At The 25th Annual Roth Conference

DENVER, COLORADO– March 12, 2013 – MusclePharm Corporation (MSLP.OB), a nutritional supplement company focused on active lifestyles, is proud to announce that it will present at the 25th Annual ROTH Conference, which will take place from March 17-20 at the Ritz-Carlton Laguna Niguel in Dana Point, California.  The MusclePharm presentation will be held on Monday March 18th at 5:30 p.m. Pacific Time.

A live webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast may access it at http://wsw.com/webcast/roth27/mslp/or on MusclePharm’s website at http://musclepharm.com/investors. An archived replay of the presentation will be available for 90 days.

ABOUT MUSCLEPHARM CORPORATION

MusclePharm is a healthy lifestyle company that develops and manufactures nutritional supplements that address active lifestyles, including muscle building, weight loss and maintaining general fitness through a daily nutritional supplement regimen. The products are formulated through a six-stage research process using the expertise of leading nutritional scientists. MusclePharm’s products are sold to consumers in more than 110 countries and available in over 10,500 U.S. retail outlets, including Dick’s Sporting Goods, GNC, Vitamin Shoppe and Vitamin World. MusclePharm products also are sold through more than 100 online channels globally, including bodybuilding.com, amazon.com and vitacost.com. For more information, please visit http://musclepharm.com/.

FORWARD-LOOKING STATEMENTS

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as “expects”, “anticipates”, “intends”, “estimates”, “plans”, “potential”, “possible”, “probable”, “believes”, “seeks”, “may”, “will”, “should”, “could” or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company’s business. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2011, the Company’s Quarter Reports on Form 10-Q and other filings submitted by the Company to the SEC, copies of which may be obtained from the SEC’s website at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.

 

MusclePharm Company Contact:

John H. Bluher, COO

Telephone:  303-618-0902

john@musclepharm.com

 

MusclePharm Investor Contact:

The Del Mar Consulting Group, Inc.                            or                     Alex Partners, LLC

Robert B. Prag, President                                                                     Scott Wilfong, President

Telephone: 858-794-9500                                                                   Telephone: 425-242-0891

Email: bprag@delmarconsulting.com                                                    Email: Scott@alexpartnersllc.com